cbdMD (YCBD) Liabilities and Shareholders Equity (2016 - 2025)

cbdMD (YCBD) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $11.8 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 2.07% year-over-year to $11.8 million; the trailing twelve-month figure through Dec 2025 stood at $43.0 million (down 14.81% YoY), and the FY2025 full-year result was $10.4 million, down 1.53% from the prior year.
• Liabilities and Shareholders Equity improved to $11.8 million in Q4 2025, from $10.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $124.9 million in Q3 2021 to a low of $9.9 million in Q2 2025.
• A 5-year average of $43.9 million and a median of $24.6 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity rose 12.67% in 2021 and plunged 67.34% in 2022, its largest moves.
• Tracing YCBD's Liabilities and Shareholders Equity over 5 years: stood at $99.3 million in 2021, then slumped by 64.03% to $35.7 million in 2022, then sank by 57.75% to $15.1 million in 2023, then decreased by 23.53% to $11.5 million in 2024, then climbed by 2.07% to $11.8 million in 2025.
• Business Quant data shows YCBD's Liabilities and Shareholders Equity at $11.8 million in Q4 2025, $10.4 million in Q3 2025, and $9.9 million in Q2 2025.